$2.00
0.021.01%
Last update: Oct 23, 4:01 PM
Genelux Corp (GNLX) Stock Price, Quote, News & History
GNLXNASDAQ
In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterranean restaurant chain Cava Group (NYSE: CAVA) made a striking...
You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.
Other companies in Genelux’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Genelux has a consensus price target of $16.71.
The stock price for Genelux (NASDAQ: GNLX) is $2.04 last updated October 23, 2026 at 4:01 PM EDT.
There are no upcoming dividends for Genelux.
Genelux does not have any upcoming earnings scheduled.
There is no upcoming split for Genelux.
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against...
